Medical News

RSS

PROLOR Biotech initiates Phase I clinical trial of its human growth hormone drug candidate

PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.

21 Sep 2009

First Edition: September 21, 2009

Today's headlines indicate that President Obama's weekend media blitz will set the stage for this week's health policy action.

21 Sep 2009

Children’s Health Network acquired by MEDNAX

MEDNAX, Inc. (NYSE: MD) has completed the acquisition of Children’s Health Network (CHN), a physician group practice that provides a variety of inpatient pediatric physician services at 11 hospitals in four states.

21 Sep 2009

Open letter to shareholders from London & Pacific Healthcare

Throughout this past year, the Board of Directors, in conjunction with the management team, key investors, business partners, employees, and experienced market consultants, has explored a variety of alternatives for significantly increasing shareholder value.

21 Sep 2009

ICF International awarded over $7M to effectively communicate substance abuse prevention

ICF International (NASDAQ:ICFI) was awarded a new, five-year contract valued at more than $7 million with the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA).

21 Sep 2009

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

21 Sep 2009

Impax Laboratories challenges Galderma Laboratories' patents

Impax Laboratories, Inc. confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its ORACEA® (doxycycline) delayed-release capsules, 40 mg.

21 Sep 2009

BRS Labs announces a video-surveillance technology that processes visual data like human brain

Behavioral Recognition Systems (BRS Labs) today announces a ground-breaking video-surveillance technology called Behavioral Analytics™, which leverages cognitive reasoning, and processes visual data on a level similar to the human brain.

21 Sep 2009

Study reveals that Europe must change perspectives towards food security

A new report by leading food and sustainability scientists calls for Europe to take a new approach on food security, prioritizing health and sustainability in research and using a holistic view when making policy. The report has been jointly chaired by Peter Raspor, professor of food science and technology at the University of Ljubljana, Slovenia and Rudy Rabbinge, professor of sustainable development and systems innovation at Wageningen University, the Netherlands.

21 Sep 2009

Sandia National Laboratories awards equipment contract to Arrayit Corporation

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences and nanotechnology technology leader, announces that on September 11th, 2009 Arrayit delivered its proprietary nanotechnology platform to Sandia National Laboratories in Albuquerque, New Mexico. Sandia Labs, managed by the Lockheed Martin Corporation, works with the Transportation Security Administration (TSA) and the Department of Homeland Security to enhance national security.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

Sleep Diagnostics assests sold to Embla Systems

Covidien, a leading global provider of healthcare products, today announced that it had completed the previously announced sale of its Sleep Diagnostics assets to Embla Systems. Financial terms of the transaction were not disclosed.

21 Sep 2009

Results of Phase 1 study of Oral AEZS-112 announced by Aeterna Zentaris

Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.

21 Sep 2009

Flu Preparedness Program offering latest information on the H1N1 virus

TeleVox Software, Inc., a leading provider of communication solutions for the healthcare industry, today launched its Flu Preparedness Program (www.televox.com/fluprogram), designed to enable health care providers to give their patients the latest information about fighting the Flu and the H1N1 virus, commonly referred to as the swine flu. Doctors can easily communicate with their patients through a variety of methods such as voice, email, postcards and text messages.

21 Sep 2009

Nutritional supplement leader Garden of Life acquired by Atrium Innovations

Atrium Innovations Inc. (TSX: ATB), a leading developer, manufacturer, and marketer of science-based and professionally supported products for the health and nutrition industry, announced today the purchase of Garden of Life, Inc., a leading formulator, distributor and marketer of nutritional supplement products.

21 Sep 2009

Programs marking Deaf Awareness Week

...

21 Sep 2009

First Analyses of TYRX's AIGISRx Anti-Bacterial Envelope Retrospective Registry

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, will present the first analyses of results from its AIGISRx Anti-Bacterial Envelope Retrospective Registry during the Transcatheter Cardiovascular Therapeutics (TCT 2009) meeting in San Francisco, CA.

21 Sep 2009

Failures in Canadian health policy

As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada’s leading economic think tanks, details the failures of Canada’s government-run health care system and serves as a warning to U.S. policy-makers.

21 Sep 2009

Forbes.com interviews CEO of GeckoSystems

GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) announced today that they are very pleased with the recent press coverage they have received from Forbes.com and other notable online authors. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

21 Sep 2009

Columbia University Medical Center performs the 100th ATS 3f Aortic Bioprosthesis implant

ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that Columbia University Medical Center has achieved 100 implants of the ATS 3f(R) Aortic Bioprosthesis. Based on the precept that 'Form Follows Function,' the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other valve.

21 Sep 2009